Levesque Eric, Winter Audrey, Noorah Zaid, Daurès Jean-Pierre, Landais Paul, Feray Cyrille, Azoulay Daniel
Department of Anaesthesia and Surgical Intensive Care - Liver ICU, AP-HP Henri Mondor Hospital, Créteil, France.
INSERM, Unité U955, Créteil, France.
Liver Int. 2017 May;37(5):684-693. doi: 10.1111/liv.13355. Epub 2017 Feb 27.
Acute-on-chronic liver failure (ACLF) is associated with a significant short-term mortality rate (23%-74%), depending on the number of organ failures. Some patients present with ACLF at the time of liver transplantation (LT). The aim of this study was to assess whether ACLF was also a prognostic factor after LT and, if applicable, to construct a score that could predict 90-day mortality.
Three hundred and fifty cirrhotic patients, who underwent LT between January 2008 and December 2013, were enrolled. We used ACLF grades according to EASL-CLIF consortium criteria to categorize the cirrhotic patients. A propensity score was applied with an Inverse Probability Treatment Weighting in a Cox model. A predictive score of early mortality after LT was generated.
One hundred and forty patients (40%) met the criteria for ACLF. The overall mortality rate at 90 days post-transplant was 10.6% (37/350 patients). ACLF at the time of LT (HR: 5.78 [3.42-9.77], P<.001) was an independent predictor of 90-day mortality. Infection occurring during the month before LT, high recipient age and male recipient, the reason for LT and a female donor were also independent risk factors for early mortality. Using these factors, we have proposed a model to predict 90-day mortality after LT.
LT is feasible in cirrhotic patients with ACLF. However, we have shown that ACLF is a significant and independent predictor of 90-day mortality. We propose a score that can identify candidate cirrhotic patients in whom LT might be associated with futile LT.
慢加急性肝衰竭(ACLF)与显著的短期死亡率(23%-74%)相关,具体取决于器官衰竭的数量。一些患者在肝移植(LT)时出现ACLF。本研究的目的是评估ACLF是否也是肝移植后的一个预后因素,如适用,构建一个能够预测90天死亡率的评分系统。
纳入2008年1月至2013年12月期间接受肝移植的350例肝硬化患者。我们根据欧洲肝脏研究学会-慢性肝衰竭(EASL-CLIF)联盟标准使用ACLF分级对肝硬化患者进行分类。在Cox模型中应用倾向评分和逆概率处理加权。生成肝移植后早期死亡率的预测评分。
140例患者(40%)符合ACLF标准。移植后90天的总死亡率为10.6%(37/350例患者)。肝移植时存在ACLF(HR:5.78[3.42-9.77],P<0.001)是90天死亡率的独立预测因素。肝移植前一个月内发生的感染、受体高龄和男性受体、肝移植原因以及女性供体也是早期死亡的独立危险因素。利用这些因素,我们提出了一个预测肝移植后90天死亡率的模型。
对于合并ACLF的肝硬化患者,肝移植是可行的。然而,我们已经表明ACLF是90天死亡率的一个重要且独立的预测因素。我们提出了一个评分系统,该系统可以识别那些肝移植可能无效的肝硬化候选患者。